Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 56

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Endothelial function and arterial stiffness in sickle-thalassemia patients

Aessopos, Athanasios, Farmakis, Dimitrios, Tsironi, Maria, Diamanti-Kandarakis, Evanthia, Matzourani, Marina, Fragodimiri, Christina, Hatziliami, Antonia, Karagiorga, Markisia·2007·Atherosclerosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2006.04.015

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 28

  1. Wang, 1999, Sickle cell anemia and other sickling syndromes, vol. 1, 1381
  2. Rodgers, 1984, Periodic microcirculatory flow in patients with sickle-cell disease, N Engl J Med, 311, 1534, 10.1056/NEJM198412133112403 · DOI
  3. Lipowsky, 1987, Intravital microscopy of capillary hemodynamics in sickle cell disease, J Clin Invest, 80, 117, 10.1172/JCI113036 · DOI
  4. Belhassen, 2001, Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation, Blood, 97, 1584, 10.1182/blood.V97.6.1584 · DOI
  5. Lemogoum, 2004, Arterial stiffness and wave reflections in patients with sickle cell disease, Hypertension, 44, 924, 10.1161/01.HYP.0000148506.73622.ba · DOI
  6. Fitch, 2001, Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats, Cardiovasc Res, 51, 351, 10.1016/S0008-6363(01)00299-1 · DOI
  7. Sahn, 1978, The committee on M-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements, Circulation, 58, 1072, 10.1161/01.CIR.58.6.1072 · DOI
  8. Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 · DOI
  9. Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X · DOI
  10. Lubien, 2002, Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings, Circulation, 105, 595, 10.1161/hc0502.103010 · DOI
  11. Stratos, 1992, Ascending aorta distensibility abnormalities in hypertensive patients and response to nifedipine administration, Am J Med, 93, 505, 10.1016/0002-9343(92)90577-X · DOI
  12. Woo, 1997, Hyperhomocysteinaemia is a risk factor for arterial endothelial dysfunction in humans, Circulation, 96, 2542, 10.1161/01.CIR.96.8.2542 · DOI
  13. Corretti, 2002, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force, J Am Coll Cardiol, 39, 257, 10.1016/S0735-1097(01)01746-6 · DOI
  14. Stuart, 1999, Sickle cell acute chest syndrome: pathogenesis and rationale for treatment, Blood, 94, 1555, 10.1182/blood.V94.5.1555 · DOI
  15. Morris, 2005, Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease, JAMA, 294, 81, 10.1001/jama.294.1.81 · DOI
  16. Aessopos, 2002, Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes, Blood, 99, 30, 10.1182/blood.V99.1.30 · DOI
  17. Aessopos, 2002, Elastic tissue abnormalities in inherited haemolytic syndromes, Eur J Clin Invest, 32, 640, 10.1046/j.1365-2362.2002.01033.x · DOI
  18. Aessopos, 1998, Arterial calcifications in beta-thalassemia, Angiology, 49, 137, 10.1177/000331979804900206 · DOI
  19. Aessopos, 1992, Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia, Am J Hematol, 41, 159, 10.1002/ajh.2830410304 · DOI
  20. Cheung, 2002, Arterial stiffness and endothelial function in patients with beta-thalassemia major, Circulation, 106, 2561, 10.1161/01.CIR.0000037225.92759.A7 · DOI
  21. Blum, 2005, Endothelial function in patients with sickle cell anemia during and after sickle cell crises, J Thromb Thrombolysis, 19, 83, 10.1007/s11239-005-1377-7 · DOI
  22. London, 2002, Prognostic application of arterial stiffness: task forces, Am J Hypertens, 15, 754, 10.1016/S0895-7061(02)02966-7 · DOI
  23. Safar, 2003, Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases, Circulation, 107, 2864, 10.1161/01.CIR.0000069826.36125.B4 · DOI
  24. Wasi, 1978, A syndrome of hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusions, Lancet, 2, 602, 10.1016/S0140-6736(78)92824-6 · DOI
  25. Aessopos, 2001, Exercise-induced myocardial perfusion abnormalities in sickle beta-thalassemia: Tc-99m tetrofosmin gated SPECT imaging study, Am J Med, 111, 355, 10.1016/S0002-9343(01)00835-X · DOI
  26. Adams, 2005, Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease, N Engl J Med, 353, 2769, 10.1056/NEJMoa050460 · DOI · Paper page
  27. Machado, 2005, Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension, Br J Haematol, 130, 445, 10.1111/j.1365-2141.2005.05625.x · DOI
  28. Derchi, 2005, Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies, Haematologica, 90, 452

Cited by

Metadata

Authors
Aessopos, A., Farmakis, D., Tsironi, M., Diamanti-Kandarakis, E., Matzourani, M., Fragodimiri, C., Hatziliami, A., & Karagiorga, M.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2007-04
Volume
191
Issue
2
Pages
427-432
ISSN
0021-9150
Cited by
56
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.